(Q52001204)

19 April 2018

title

Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits. (English)

1 reference

19 April 2018

1 reference

13

1 reference

19 April 2018

Karen I Winey

11

object named as

Karen I Winey

1 reference

19 April 2018

Neal R. Swerdlow

12

object named as

Neal R Swerdlow

1 reference

19 April 2018

author name string

Kayla L Metzger

1

1 reference

19 April 2018

Jody M Shoemaker

2

1 reference

19 April 2018

Jonathan B Kahn

3

1 reference

19 April 2018

Christina R Maxwell

4

1 reference

19 April 2018

Yuling Liang

5

1 reference

19 April 2018

Jan Tokarczyk

6

1 reference

19 April 2018

Stephen J Kanes

7

1 reference

19 April 2018

Meredith Hans

8

1 reference

19 April 2018

Anthony M Lowman

9

1 reference

19 April 2018

Nily Dan

10

1 reference

19 April 2018

publication date

21 November 2006

1 reference

19 April 2018

number of pages

11

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

19 April 2018

volume

190

1 reference

19 April 2018

issue

2

1 reference

19 April 2018

page(s)

201-211

1 reference

19 April 2018

Biodegradable microspheres in drug delivery

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-006-0616-8

Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-006-0616-8

Sensorimotor gating deficits in transgenic mice expressing a constitutively active form of Gs alpha

21 January 2018

1 reference

12 December 2020

Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia

1 reference

12 December 2020

Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia

1 reference

12 December 2020

Use patterns for antipsychotic medications in medicaid patients with schizophrenia.

1 reference

12 December 2020

Association between adherence to diuretic therapy and health care utilization in patients with heart failure

1 reference

12 December 2020

Haloperidol serum concentrations and D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate

1 reference

12 December 2020

Guidelines for depot antipsychotic treatment in schizophrenia

1 reference

12 December 2020

Interactive risk factors for treatment adherence in a chronic psychotic disorders population.

1 reference

12 December 2020

Therapeutic applications of implantable drug delivery systems

1 reference

12 December 2020

Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapine

1 reference

12 December 2020

A meta-analysis of the efficacy of second-generation antipsychotics

1 reference

12 December 2020

Medication adherence in patients with HIV infection: a comparison of two measurement methods

1 reference

12 December 2020

Analysis of drug release kinetics from degradable polymeric devices.

1 reference

12 December 2020

Systematic meta-review of depot antipsychotic drugs for people with schizophrenia

1 reference

12 December 2020

Psychopharmacology: Perspectives on medication adherence and atypical antipsychotic medications.

1 reference

12 December 2020

Controlled release of cisplatin incorporated into biodegradable poly-d, l-lactic acid.

1 reference

12 December 2020

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

12 December 2020

Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine

1 reference

12 December 2020

Using drug claims data to assess the relationship of medication adherence with hospitalization and costs

1 reference

12 December 2020

Consent and long-term neuroleptic treatment

1 reference

12 December 2020

Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection

1 reference

12 December 2020

Clinical trials in psychiatry: do results apply to practice?

1 reference

12 December 2020

Poly(lactic/glycolic acid) biodegradable drug-polymer matrix systems

1 reference

12 December 2020

Utilization of oral hypoglycemic agents in a drug-insured U.S. population

1 reference

12 December 2020

Factors influencing relapse in the long-term course of schizophrenia.

1 reference

12 December 2020

Predicting medication noncompliance after hospital discharge among patients with schizophrenia

1 reference

12 December 2020

Development of drug delivery systems for use in treatment of narcotic addiction.

1 reference

12 December 2020

Treatment Adherence Associated With Conventional and Atypical Antipsychotics in a Large State Medicaid Program

1 reference

12 December 2020

Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder.

1 reference

12 December 2020

Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidone

1 reference

12 December 2020

Progress in HIV therapeutics and the challenges of adherence to antiretroviral therapy

1 reference

12 December 2020

Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats

1 reference

12 December 2020

Effect of drug type on the degradation rate of PLGA matrices

1 reference

12 December 2020

Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial

1 reference

12 December 2020

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

1 reference

12 December 2020

10.1007/S00213-006-0616-8

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018